前收市價 | 0.9500 |
開市 | 1.0500 |
買盤 | 0.0000 |
賣出價 | 4.8000 |
拍板 | 10.00 |
到期日 | 2024-05-17 |
今日波幅 | 1.0500 - 1.0500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3 |
Solid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease Designation for the treatment of Duchenne muscular dystrophy.
Solid Biosciences is shrugging off several messy years in gene therapy development. The biotech stock has gotten a triple-digit boost.
In this article, we will take a detailed look at 14 Stocks With Heavy Insider Buying In 2024. For a quick overview of such stocks, read our article 5 Stocks With Heavy Insider Buying In 2024. Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months […]